The United Kingdom Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry)
NCT03832881 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2019-02-06
Summary
This is a UK (United Kingdom) based registry, involving all sites treating newly presenting Thrombotic Thrombocytopenic Purpura (TTP). From this registry, important epidemiological data will be obtained. Admission and remission samples will be collected. DNA will be collected and analysed from patients wishing to participate to determine if any link exists between mutations/polymorphisms and the risk of TTP. As part of NHS commissioning, we will be undertaking long term follow up, to understand the impact of acute TTP on morbidity and mortality.
Conditions
- TTP - Thrombotic Thrombocytopenic Purpura
Interventions
- DIAGNOSTIC_TEST
-
ADAMTS13, VWF assay
Sponsors & Collaborators
-
University College, London
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2023-11-30
- Completion
- 2023-11-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
ADAMTS13 in Thrombotic Thrombocytopenic Purpura
NCT00426686 ·Status: COMPLETED
-
Italian iTTP Registry
NCT06376786 ·Status: RECRUITING
-
Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
NCT00251277 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care
NCT03237819 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
NCT01554514 ·Status: COMPLETED ·Phase: PHASE2
-
Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry
NCT05914441 ·Status: RECRUITING
-
Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura
NCT06291025 ·Status: RECRUITING ·Phase: NA
-
The International ITP Registry
NCT01970189 ·Status: UNKNOWN
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP
NCT04720261 ·Status: TERMINATED ·Phase: PHASE2
-
Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
NCT07205861 ·Status: RECRUITING
-
A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)
NCT03393975 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts
NCT05583838 ·Status: COMPLETED ·Phase: PHASE4
-
NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults
NCT01172015 ·Status: COMPLETED ·Phase: NA
-
Construction of a Database for TTP
NCT05571774 ·Status: RECRUITING
-
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
NCT04323748 ·Status: RECRUITING ·Phase: PHASE1
-
Investigation on a Dynamic Cohort of Italian Patients With Active ITP
NCT03465020 ·Status: UNKNOWN
-
Efficacy and Safety of IVIG-L in ITP Patients
NCT00151840 ·Status: COMPLETED ·Phase: PHASE3
-
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
NCT00005570 ·Status: COMPLETED
-
Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
NCT00907751 ·Status: COMPLETED ·Phase: PHASE2
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
NCT03922308 ·Status: COMPLETED ·Phase: PHASE2
-
Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?
NCT04128358 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT00828750 ·Status: COMPLETED ·Phase: PHASE3